Real-Life Effectiveness of MP-AzeFlu (Dymista^®) in Swedish Patients with Persistent Allergic Rhinitis, Assessed by the Visual Analogue Scale

References

• Valovirta E, Myrseth SE, Palkonen S. The voice of the patients: allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin Immunol. 2008;8(1):1–9. doi:10.1097/ACI.0b013e3282f3f42f
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and allergen). Allergy. 2008;63(Suppl 86):8–160. doi:10.1111/j.1398-9995.2007.01620.x
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schünemann HJ, Hellings PW, et al. Macvia clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–74. e2. doi:10.1016/j.jaci.2016.03.025
   PubMed Web of Science ®Google Scholar
• Bousquet PJ, Combescure C, Klossek JM, Daures JP, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol. 2009;123(6):1349–1354.
   PubMed Web of Science ®Google Scholar
• Demoly P, Bousquet PJ, Mesbah K, Bousquet J, Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy. 2013;43(8):881–888.
   PubMed Web of Science ®Google Scholar
• Spc dymista nasal spray; 2015. Available from: https://www.medicines.org.uk/emc/medicine/27579. Accessed August 8, 2017.
   Google Scholar
• Klimek L, Bachert C, Stjarne P, et al. Mp-AzeFlu provides rapid and effective allergic rhinitis control in real life: a pan-European study. Allergy Asthma Proc. 2016;37(5):376–386.
   PubMed Web of Science ®Google Scholar
• Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol. 2012;129(5):1282–9. e10.
   PubMed Web of Science ®Google Scholar
• Agache I, Doros IC, Leru PM, Bucur I, Poenaru M, Sarafoleanu C. Mp-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania. Rhinology. 2018;56(1):33–41.
   PubMed Web of Science ®Google Scholar
• Dollner R, Lorentz Larsen P, Dheyauldeen S, Steinsvag S. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with Mp-AzeFlu. Allergy Rhinol. 2017;8(3):148–156. doi:10.2500/ar.2017.8.0216
   PubMedGoogle Scholar
• Klimek L, Bachert C, Mosges R, et al. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study. Allergy Asthma Proc. 2015;36(1):40–47. doi:10.2500/aap.2015.36.3823
   PubMed Web of Science ®Google Scholar
• Bousquet J, Price D, Meltzer EO, et al. Onset of action for intranasal azelastine–fluticasone propionate versus oral loratadine with intranasal fluticasone propionate. Presented at: 2017 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology; October 26–30, 2017; Boston, MA. Abstract P502.
   Google Scholar
• Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc. 2012;33(4):324–332. doi:10.2500/aap.2012.33.3587
   PubMed Web of Science ®Google Scholar
• Stjärne P, Pohl W, Kaulsay R. Mp-AzeFlu®* improves sleep quality in patients with persistent allergic rhinitis: data from Austria, Ireland and Sweden. Poster presented at: 2017 European Academy of Allergy and Clinical Immunology Congress; June 17‒21, 2017; Helsinki, Finland.
   Google Scholar
• Benninger MS, Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc. 2009;30(4):358–365. doi:10.2500/aap.2009.30.3244
   PubMed Web of Science ®Google Scholar
• Craig TJ, Sherkat A, Safaee S. Congestion and sleep impairment in allergic rhinitis. Curr Allergy Asthma Rep. 2010;10(2):113–121. doi:10.1007/s11882-010-0091-5
   PubMed Web of Science ®Google Scholar
• Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg. 2004;130(5):617–629. doi:10.1016/j.otohns.2004.02.001
   PubMed Web of Science ®Google Scholar
• Storms W. Allergic rhinitis-induced nasal congestion: its impact on sleep quality. Prim Care Respir J. 2008;17(1):7–18. doi:10.3132/pcrj.2008.00001
   PubMedGoogle Scholar
• Stull DE, Roberts L, Frank L, Heithoff K. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin. 2007;23(4):811–819. doi:10.1185/030079907X178793
   PubMed Web of Science ®Google Scholar
• Thompson A, Sardana N, Craig TJ. Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation. Ann Allergy Asthma Immunol. 2013;111(6):446–451. doi:10.1016/j.anai.2013.05.020
   PubMed Web of Science ®Google Scholar
• Bousquet J, Annesi-Maesano I, Carat F, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy. 2005;35(6):728–732. doi:10.1111/j.1365-2222.2005.02274.x
   PubMed Web of Science ®Google Scholar
• Berger WE, Shah S, Lieberman P, et al. Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis. J Allergy Clin Immunol Pract. 2014;2(2):179–185. doi:10.1016/j.jaip.2013.09.019
   PubMed Web of Science ®Google Scholar
• Price D, Shah S, Bhatia S, et al. A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis. J Investig Allergol Clin Immunol. 2013;23(7):495–503.
   PubMed Web of Science ®Google Scholar